Isotechnika, Aurinia merge
Isotechnika Pharma Inc. (immunomodulating therapeutics) has agreed to acquire Aurinia Pharmaceuticals Inc. (lupus and nephrology drug candidate), forming a global nephrology firm that will keep the Aurinia name. Istoechnika will own 65% of the company post-merger.
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Reverse Acquisition
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com